Using ice packs to reduce pain from needle insertion in dialysis patients
Response Of Arteriovenous Fistula Puncture-related Pain To Cryotherapy Application In Haemodialysis Patients
NA · Cairo University · NCT06520631
This study is testing if using ice packs before needle insertion can help reduce pain for dialysis patients.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 30 Years to 50 Years |
| Sex | All |
| Sponsor | Cairo University (other) |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06520631 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of cryotherapy, specifically the application of ice packs, in reducing pain associated with arteriovenous fistula puncture during hemodialysis. Ninety patients aged 30-50 with end-stage renal disease will be randomly assigned to three groups: one receiving ice packs at the cannulation site, another receiving ice packs at a contralateral site, and a control group with no ice application. The intervention will be conducted over 20 sessions, with ice packs applied for 5-10 minutes before dialysis. The goal is to assess whether cryotherapy can alleviate the significant pain and anxiety experienced by patients during needle insertion.
Who should consider this trial
Good fit: Ideal candidates are patients aged 30-50 with end-stage kidney failure undergoing regular hemodialysis for more than three months.
Not a fit: Patients with advanced age, severe comorbidities, or conditions that contraindicate cold therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for hemodialysis patients by reducing pain and anxiety during treatment.
How similar studies have performed: Previous studies have shown positive effects of cryotherapy on pain relief in similar contexts, suggesting potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The study includes patients with ages from 30 to 50 years. * Patients able to report pain adequately. * Patients with end-stage kidney failure undergoing regular hemodialysis who have been treated for more than 3 months, at least twice per week, with arteriovenous fistula in use for more than 1 month are included in the study. Exclusion Criteria: Patients with conditions such as * advanced age, * advanced diabetes, * cardiovascular insufficiency, * cold allergy, * Reynaud's phenomenon, * nerve and tissue damage, * fractures, * heart failure, * uncooperative patients, * cognitive impairment preventing a proper assessment of pain.
Where this trial is running
Cairo
- Cairo university — Cairo, Egypt (RECRUITING)
Study contacts
- Study coordinator: Sara Fathy El-said, Physical therapist
- Email: saraghoneem581@gmail.com
- Phone: 01205692600
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hemodialysis Complication